Results: 1-25/156
Authors:
Losito, A
Gaburri, M
Errico, R
Parente, B
Cao, PG
Citation: A. Losito et al., Survival of patients with renovascular disease and ACE inhibition, CLIN NEPHR, 52(6), 1999, pp. 339-343
Authors:
Brijker, F
Magee, CC
Tervaert, JWC
O'Neill, S
Walshe, JJ
Citation: F. Brijker et al., Outcome analysis of patients with vasculitis associated with antineutrophil cytoplasmic antibodies, CLIN NEPHR, 52(6), 1999, pp. 344-351
Authors:
Small, G
Watson, AR
Evans, JHC
Gallagher, J
Citation: G. Small et al., Hemolytic uremic syndrome: defining the need for long-term follow-up, CLIN NEPHR, 52(6), 1999, pp. 352-356
Authors:
Ikeda, K
Ida, O
Kimoto, K
Takatorige, T
Nakanishi, N
Tatara, K
Citation: K. Ikeda et al., Effect of early fosfomycin treatment on prevention of hemolytic uremic syndrome accompanying Escherichia coli O157 : H7 infection, CLIN NEPHR, 52(6), 1999, pp. 357-362
Authors:
Harmoinen, APT
Kouri, TT
Wirta, OR
Lehtimaki, TJ
Rantalaiho, V
Turjanmaa, VMH
Pasternack, AI
Citation: Apt. Harmoinen et al., Evaluation of plasma cystatin C as a marker for glomerular filtration ratein patients with type 2 diabetes, CLIN NEPHR, 52(6), 1999, pp. 363-370
Authors:
Bokenkamp, A
Ozden, N
Dieterich, C
Schumann, G
Ehrich, JHH
Brodehl, J
Citation: A. Bokenkamp et al., Cystatin C and creatinine after successful kidney transplantation in children, CLIN NEPHR, 52(6), 1999, pp. 371-376
Authors:
Tucker, B
Fabbian, F
Giles, M
Johnston, A
Baker, LRI
Citation: B. Tucker et al., Reduction of left ventricular mass index with blood pressure reduction in chronic renal failure, CLIN NEPHR, 52(6), 1999, pp. 377-382
Authors:
van Ginneken, EEM
Assmann, KJM
Koolen, MI
Jansen, JLJ
Wetzels, JFM
Citation: Eem. Van Ginneken et al., Fibrillary-immunotactoid glomerulopathy with renal deposits of IgA lambda:a rare cause of glomerulonephritis, CLIN NEPHR, 52(6), 1999, pp. 383-389
Authors:
Wang, JY
Chu, P
Ko, CT
Chiu, CH
Lin, YF
Citation: Jy. Wang et al., Pericardial tamponade in chronic dialysis patients: transesophageal echocardiogram during pericardial drainage, CLIN NEPHR, 52(6), 1999, pp. 390-392
Authors:
Huber, FX
Herzog, L
Werle, E
Glaser, F
Citation: Fx. Huber et al., Crush syndrome in polytrauma - octreotide in a novel therapeutic concept, CLIN NEPHR, 52(6), 1999, pp. 392-394
Authors:
Grcevska, L
Polenakovic, M
Citation: L. Grcevska et M. Polenakovic, A long-term follow-up (21 years) of a patient with class III lupus nephritis - complete remission of the renal involvement and death because of CNS involvement, CLIN NEPHR, 52(6), 1999, pp. 394-397
Authors:
Kurt, E
Manavoglu, O
Dilek, K
Orhan, B
Evrensel, T
Citation: E. Kurt et al., Effect of cisplatin on plasma renin activity and serum aldosterone levels, CLIN NEPHR, 52(6), 1999, pp. 397-398
Authors:
Ambuhl, PA
Muller, V
Binswanger, U
Citation: Pa. Ambuhl et al., Transient proteinuria after infusion of a gelatin plasma volume expander, CLIN NEPHR, 52(6), 1999, pp. 399-400
Authors:
Malluche, HH
Monier-Faugere, MC
Citation: Hh. Malluche et Mc. Monier-faugere, Understanding and managing hyperphosphatemia in patients with chronic renal disease, CLIN NEPHR, 52(5), 1999, pp. 267-277
Authors:
Kondo, S
Yoshizawa, N
Kusumi, Y
Takeuchi, A
Torikata, C
Citation: S. Kondo et al., Studies of glomerular permeability factor (GPF) in focal segmental glomerular sclerosis and the relationship between GPF and vascular permeability factor (VPF), CLIN NEPHR, 52(5), 1999, pp. 278-284
Authors:
Scholl, U
Wastl, U
Risler, T
Braun, N
Grabensee, B
Heering, P
Schollmeyer, P
Zauner, I
Stein, G
Funfstuck, R
Keller, F
Citation: U. Scholl et al., The "point of no return" and the rate of progression in the natural history of IgA nephritis, CLIN NEPHR, 52(5), 1999, pp. 285-292
Authors:
Yorioka, N
Taniguchi, Y
Amimoto, D
Ogata, S
Sakikubo, E
Yamakido, M
Naito, T
Shimamoto, F
Citation: N. Yorioka et al., Clinicopathological study of myeloperoxidase anti-neutrophil cytoplasmic antibody-associated glomerulonephritis, CLIN NEPHR, 52(5), 1999, pp. 293-296
Authors:
Koch, VH
Furusawa, EA
Saito, MI
Colli, A
Ignes, EC
Okay, Y
Junior, DM
Citation: Vh. Koch et al., White coat hypertension in adolescents, CLIN NEPHR, 52(5), 1999, pp. 297-303
Authors:
Katzarski, KS
Randmaa, I
Bergstrom, J
Citation: Ks. Katzarski et al., Influence of hemodialysis on intravascular volume and vasoactive hormones, CLIN NEPHR, 52(5), 1999, pp. 304-311
Authors:
Mrowka, C
Heintz, B
Sieberth, HG
Citation: C. Mrowka et al., Is dialysis membrane type responsible for increased circulating adhesion molecules during chronic hemodialysis?, CLIN NEPHR, 52(5), 1999, pp. 312-321
Authors:
Vanuytsel, JL
Lins, RL
Zachee, P
Mattheeussen, J
Hosten, S
Lens, S
Daelemans, R
Citation: Jl. Vanuytsel et al., Comparison of different routes of administration of nadroparin in hemodialysis, CLIN NEPHR, 52(5), 1999, pp. 322-325
Authors:
Coyle, JM
Kumwenda, MJ
Wright, FW
Citation: Jm. Coyle et al., Henoch Schoenlein nephritis, CLIN NEPHR, 52(5), 1999, pp. 326-328
Authors:
Kitoh, C
Miyagi, K
Onoe, T
Katano, K
Shimada, T
Takegoshi, T
Citation: C. Kitoh et al., Reversible peritoneal calcification in a patient treated by CAPD, CLIN NEPHR, 52(5), 1999, pp. 329-332
Authors:
Qun, L
Luo, Q
Zhang, ZY
Chen, YC
Zhang, JB
Dong, H
Lin, DH
Citation: L. Qun et al., Effects of astragalus on IL-2/IL-2R system in patients with maintained hemodialysis, CLIN NEPHR, 52(5), 1999, pp. 333-334
Authors:
Jorge, C
Gil, C
Possante, M
Catarino, MC
Cruz, A
Andrade, R
Teixeira, R
Santos, N
Ferreira, A
Citation: C. Jorge et al., Use of a desferrioxamine "microdose" to chelate aluminum in hemodialysis patients, CLIN NEPHR, 52(5), 1999, pp. 335-336